|
The FUNNEL: A molecular multiplex triage for precision medicine in metastatic colorectal cancer. |
|
|
No Relationships to Disclose |
|
|
Research Funding - Boehringer Ingelheim (Inst); H3 Biomedicine (Inst); Symphony Evolution (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Celgene; Novartis; Roche Pharma AG |
|
|
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck KGaA; Roche Pharma AG; Sanofi |
|
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Other Relationship - Amgen; Bayer; Lilly; Roche |
|
|
Speakers' Bureau - GE Healthcare |
Patents, Royalties, Other Intellectual Property - Springer |
Travel, Accommodations, Expenses - Bayer; Bracco Diagnostics; GE Healthcare |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Horizon Discovery |
Consulting or Advisory Role - Biocartis; Horizon Discovery; Trovagene |
Speakers' Bureau - Novartis |
|
|
Other Relationship - Merus |
|
|
No Relationships to Disclose |